Tamoxifen
Tamoxifen

0.32
Inhibits malignant cellular proliferation for Women's Health and Oncology Support by antagonizing specific hormone-sensitive pathways to starve estrogen-dependent tumor tissues and prevent recurrent growths.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tamoxifen
Reference Brand
Nolvadex
Product Origin
Generic Product
Reference Manufacturer
AstraZeneca
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Women's Health, Oncology Support
Product Category
Antiestrogen
Pharmacological Class
Selective Estrogen Receptor Modulator
Clinical Indications
Breast cancer treatment, Prevention of breast cancer
Manufacturer Description
Tamoxifen is indicated to manage estrogen-sensitive breast cancer, utilized to alleviate the risk of cancer progression and support long-term hormone-based therapy for women.
Mechanism of Action
Tamoxifen is a selective estrogen receptor modulator that blocks the effects of estrogen in breast tissue, thus inhibiting the proliferation of hormone-receptor-positive cancer cells.
Route of Administration
Oral
Onset Time
Weeks to months
Duration
24 hours
Contraindications
History of deep vein thrombosis, Pregnancy
Severe Adverse Events
Uterine cancer, Blood clots
Common Side Effects
Hot flashes, Vaginal discharge
Uncommon Side Effects
Nausea, Weight gain
Drug Interactions
Warfarin, Paroxetine
Pregnancy Safety Warnings
Not safe for use during pregnancy.
Age Restrictions
Adult use only.
Storage Guidelines
Store at room temperature.
Related Products
Raloxifene

Tamoxifen FAQ

How do digital health platforms facilitate evaluation and access to Tamoxifen in Singapore?

Telehealth and digital health directories facilitate access by connecting patients with remote consultations, allowing for the review of medical history and evidence-based evaluation before obtaining the required documentation.

Why are there cost variations between multi-source generic Tamoxifen formulations and originator brands?

Formulation economics dictate that generic manufacturers produce bioequivalent versions without the initial research and development overheads borne by originator developers, resulting in different procurement costs.

How can patients in Singapore verify the regulatory compliance of digital health directories?

Verification involves ensuring that providers operate in accordance with Health Sciences Authority guidelines and prioritize verifiable supply chains for the distribution of medicinal compounds.

What are the logistical considerations when utilizing cross-border facilitation for Tamoxifen?

Importing specialized medications into Singapore requires adherence to personal import regulations, which may dictate specific quantity limits and documentation requirements to ensure regulatory alignment.

Is the generic Tamoxifen formulation clinically bioequivalent to other options?

The generic formulation described serves as a bioequivalent, match-verified version of the originator composition, ensuring that physiological activity and absorption profiles remain consistent with standard therapeutic expectations.

What is Tamoxifen?

Targeting specific hormonal pathways, Tamoxifen serves as a selective modulator of estrogen receptors. Medical practice utilizes this compound to balance hormonal influences across various tissues within Women's Health and Oncology Support frameworks. Biological activity centers on inhibiting the binding of circulating estrogens to cellular receptor sites.

Health professionals incorporate this non-steroidal agent into broader long-term management plans. Clinical objectives focus on reducing the risk of recurrence among patient populations requiring estrogen modulation. Consistent utilization supports therapeutic goals established by oncology teams.

Regulatory & Classification Profile

Singapore categorizes Tamoxifen as a Prescription-Only Medicine. Regulatory frameworks implemented by the Health Sciences Authority oversee the distribution and clinical management of this compound. Access to this medication necessitates professional consultation within the local healthcare system to ensure adherence to safety standards.

Formulations & Associated Medications

Tamoxifen functions as a bioequivalent generic formulation containing the active ingredient Tamoxifen. Digital health directories facilitate access to this medication through diverse logistics networks. Available formulations accessible through our website include Tamoxifen pill in strengths of 10mg and 20mg.

Therapeutic Applications

  • Managing estrogen-receptor-positive breast cancer in adult patients.
  • Assisting in the reduction of contralateral breast cancer risk.
  • Supporting therapeutic protocols for patients diagnosed with early-stage disease.
  • Addressing symptom progression in advanced oncological settings.
  • Facilitating hormonal control for specifically diagnosed patient populations.

Biological Action

Tamoxifen attaches to hormone receptors located inside cells. Competition for these binding sites prevents estrogens from exerting their typical proliferative effects on sensitive tissues. Downstream biological signals decrease, which slows the physiological processes associated with hormonal tumor growth. Cellular activity transitions toward a more stable state through this competitive inhibition process.

Treatment Landscape & Drug Class

Selective Estrogen Receptor Modulators (SERMs) constitute the chemical family encompassing Tamoxifen. Modern clinical protocols utilize these compounds to provide targeted hormonal intervention. Therapeutic strategies frequently involve long-term systemic administration to maintain stable receptor modulation levels throughout the body.

Understanding the Safety Profile

Physiological involvement includes hepatic metabolism and potential systemic distribution across central nervous system pathways. Clinical monitoring remains vital to track the impact of the compound on metabolic and vascular homeostasis. Systemic circulation facilitates therapeutic efficacy while requiring strict adherence to medical oversight guidelines. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

Educational material regarding Tamoxifen provides a foundational overview of its role in oncology support. Medicines like Tamoxifen differ in strength based on formulation and individual patient requirements. Clinical liability for specific outcomes remains outside the scope of this information. Always consult labeling documentation and a qualified healthcare professional to determine if a specific therapeutic path satisfies individual health needs and complies with established medical standards within the local jurisdiction of Singapore.

Clinical Glossary

Selective Estrogen Receptor Modulators
Compounds that interact with hormone receptors to produce tissue-specific responses.
Bioequivalence
Equality in the rate and extent to which an active ingredient is absorbed into the bloodstream.
Estrogen Receptor Positive
Cellular status indicating that tumor growth is stimulated by hormones.
Systemic Absorption
Process where a compound enters the circulatory system for distribution to target tissues.
Information associated with Tamoxifen is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories